Multifunctional titanium phosphate carriers for enhancing drug delivery and evaluating real-time therapeutic efficacy of a hydrophobic drug component in
Nanoparticles are often used to serve as drug delivery systems to improve the therapeutic efficacy of some hydrophobic drugs. In this work, PEG and peptide-modified titanium phosphate nanoparticles (TiP-PEG/peptide) were synthesized to enhance the drug delivery efficacy of tirucalla-8,24-diene-3β,11...
Saved in:
Published in | Analyst (London) Vol. 146; no. 5; pp. 162 - 1625 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Published |
08.03.2021
|
Online Access | Get full text |
Cover
Loading…
Summary: | Nanoparticles are often used to serve as drug delivery systems to improve the therapeutic efficacy of some hydrophobic drugs. In this work, PEG and peptide-modified titanium phosphate nanoparticles (TiP-PEG/peptide) were synthesized to enhance the drug delivery efficacy of tirucalla-8,24-diene-3β,11β-diol-7-one (KS-01), a major bioactive and hydrophobic component extracted from
Euphorbia kansui
. This drug delivery system with a loading efficiency of about 29.8 mg KS-01/1 g TiP-PEG/peptide exerted a significantly lower cell viability rate of MCF-7 than free KS-01, indicating that these carriers can effectively increase the therapeutic efficacy by improving its water solubility. Moreover, according to the fluorescence intensity of FAM which can be generated by caspase-3 cleaving DEVD-embedded peptide, the caspase-3 level could be determined and the therapeutic efficacy could be visualized in real time.
TiP-PEG/peptide nanocarriers were constructed to enhance hydrophilic drug delivery efficiency and determine real-time therapeutic efficacy according to the fluorescence intensity of FAM triggered by caspase-3. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available: The standard curve of caspase-3 detected 10.1039/d1an00163a an assay kit and KS-01 in different concentrations detected by HPLC. See DOI via |
ISSN: | 0003-2654 1364-5528 |
DOI: | 10.1039/d1an00163a |